Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biochim Biophys Acta Mol Basis Dis ; 1865(6): 1604-1616, 2019 06 01.
Article in English | MEDLINE | ID: mdl-30910704

ABSTRACT

Pulmonary hypertension (PH) is characterized by a thickening of the distal pulmonary arteries caused by medial hypertrophy, intimal proliferation and vascular fibrosis. Low density lipoprotein receptor-related protein 1 (LRP1) maintains vascular homeostasis by mediating endocytosis of numerous ligands and by initiating and regulating signaling pathways. Here, we demonstrate the increased levels of LRP1 protein in the lungs of idiopathic pulmonary arterial hypertension (IPAH) patients, hypoxia-exposed mice, and monocrotaline-treated rats. Platelet-derived growth factor (PDGF)-BB upregulated LRP1 expression in pulmonary artery smooth muscle cells (PASMC). This effect was reversed by the PDGF-BB neutralizing antibody or the PDGF receptor antagonist. Depletion of LRP1 decreased proliferation of donor and IPAH PASMC in a ß1-integrin-dependent manner. Furthermore, LRP1 silencing attenuated the expression of fibronectin and collagen I and increased the levels of α-smooth muscle actin and myocardin in donor, but not in IPAH, PASMC. In addition, smooth muscle cell (SMC)-specific LRP1 knockout augmented α-SMA expression in pulmonary vessels and reduced SMC proliferation in 3D ex vivo murine lung tissue cultures. In conclusion, our results indicate that LRP1 promotes the dedifferentiation of PASMC from a contractile to a synthetic phenotype thus suggesting its contribution to vascular remodeling in PH.


Subject(s)
Becaplermin/genetics , Cell Dedifferentiation/genetics , Familial Primary Pulmonary Hypertension/genetics , Low Density Lipoprotein Receptor-Related Protein-1/genetics , Myocytes, Smooth Muscle/metabolism , Actins/genetics , Actins/metabolism , Adult , Animals , Antibodies, Neutralizing/pharmacology , Becaplermin/antagonists & inhibitors , Becaplermin/metabolism , Case-Control Studies , Cell Proliferation/drug effects , Collagen Type I/genetics , Collagen Type I/metabolism , Disease Models, Animal , Familial Primary Pulmonary Hypertension/chemically induced , Familial Primary Pulmonary Hypertension/metabolism , Familial Primary Pulmonary Hypertension/pathology , Female , Fibronectins/genetics , Fibronectins/metabolism , Gene Expression Regulation , Homeostasis/genetics , Humans , Integrin beta1/genetics , Integrin beta1/metabolism , Low Density Lipoprotein Receptor-Related Protein-1/antagonists & inhibitors , Low Density Lipoprotein Receptor-Related Protein-1/metabolism , Male , Mice , Middle Aged , Monocrotaline/administration & dosage , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/pathology , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Pulmonary Artery/drug effects , Pulmonary Artery/metabolism , Pulmonary Artery/pathology , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Rats , Receptors, Platelet-Derived Growth Factor/genetics , Receptors, Platelet-Derived Growth Factor/metabolism , Signal Transduction , Tissue Culture Techniques , Trans-Activators/genetics , Trans-Activators/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...